The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas.
 
Emeline Tabouret
Consulting or Advisory Role - GLIOCURE; Leo Pharma
Research Funding - Leo Pharma
Travel, Accommodations, Expenses - Novocure
 
Julia Furtner
No Relationships to Disclose
 
Thomas Graillon
No Relationships to Disclose
 
Antonio Silvani
No Relationships to Disclose
 
Emilie Le Rhun
Honoraria - Bayer (I); Novocure (I); Pierre Fabre
Consulting or Advisory Role - Bayer; CureVac (I); Janssen; Leo Pharma; Medac (I); Novartis (I); Orbus Therapeutics (I); Philogen (I); Roche (I); Sandoz (I); Seagen
Research Funding - Bristol-Myers Squibb (Inst)
 
Riccardo Soffietti
No Relationships to Disclose
 
Giuseppe Lombardi
No Relationships to Disclose
 
Juan Manuel Sepulveda
No Relationships to Disclose
 
Petter Brandal
Travel, Accommodations, Expenses - IBA
 
Lucy Brazil
No Relationships to Disclose
 
Martin Bendszus
No Relationships to Disclose
 
Vassilis Golfinopoulos
No Relationships to Disclose
 
Thierry Gorlia
No Relationships to Disclose
 
Michael Weller
Honoraria - Bayer; Novocure
Consulting or Advisory Role - Bayer (I); Curevac; Janssen (I); LEO Pharma (I); Medac; Novartis; Orbus Therapeutics; Philogen; Pierre Fabre (I); Roche; Sandoz; Seagen (I)
Research Funding - Quercegen Pharmaceuticals (Inst); Versameb (Inst)
 
Felix Sahm
No Relationships to Disclose
 
Wolfgang Wick
No Relationships to Disclose
 
Matthias Preusser
Honoraria - Abbvie; Adastra Pharmaceuticals; AstraZeneca; Bayer; BMJ Journals; Bristol-Myers Squibb; CMC Contrast; Daiichi Sankyo; Gan & Lee; Gerson Lehrman Group; GlaxoSmithKline; Lilly; Medahead; MedMedia; Merck Sharp & Dome; Mundipharma; Novartis; Roche; Sanofi; Tocagen
Consulting or Advisory Role - AbbVie; Bristol-Myers Squibb; CMC Contrast; Gerson Lehrman Group; GlaxoSmithKline; Mundipharma; Novartis; Roche
Research Funding - AbbVie (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Merck Sharp & Dohme; Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Mundipharma; Roche